The clinically tested N-methyl-d-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy

This publication has 19 references indexed in Scilit:

• The effects of the clinically tested NMDA receptor antagonist memantine on carrageenan-induced thermal hyperalgesia in rats
  European Journal of Pharmacology, 1994
• The NMDA antagonist memantine blocks pain behavior in a rat model of formalin-induced facial pain
  Pain, 1993
• MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy
  Brain Research, 1991
• Evidence for spinalN-methyl-d-aspartate receptor involvement in prolonged chemical nociception in the rat
  Brain Research, 1990
• Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord
  Pain, 1990
• Tachykinins and calcitonin gene-related peptide enhance release of endogenous glutamate and aspartate from the rat spinal dorsal horn slice
  Journal of Neuroscience, 1990
• Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels
  European Journal of Pharmacology, 1989
• A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
  Pain, 1988
• A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
  PAIN®, 1988
• Evidence for involvement ofN-methylaspartate receptors in ‘wind-up’ of class 2 neurones in the dorsal horn of the rat
  Brain Research, 1987